Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
33.23
+0.15 (0.45%)
May 9, 2025, 1:02 PM - Market open
Enovis Revenue
Enovis had revenue of $558.83M in the quarter ending April 4, 2025, with 8.25% growth. This brings the company's revenue in the last twelve months to $2.15B, up 18.32% year-over-year. In the year 2024, Enovis had annual revenue of $2.11B with 23.46% growth.
Revenue (ttm)
$2.15B
Revenue Growth
+18.32%
P/S Ratio
0.86
Revenue / Employee
$291,868
Employees
7,367
Market Cap
1.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.11B | 400.43M | 23.46% |
Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ENOV News
- 1 day ago - Enovis Announces First Quarter 2025 Results - GlobeNewsWire
- 22 days ago - Enovis to Host First Quarter 2025 Results Conference Call on May 8th - GlobeNewsWire
- 5 weeks ago - Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - GlobeNewsWire
- 6 weeks ago - Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewsWire
- 2 months ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Enovis Continues To Languish Despite Decent Financial Results - Seeking Alpha
- 2 months ago - Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Enovis Announces Fourth Quarter and Full Year 2024 Results - GlobeNewsWire